Guideline document

Your browser can't display PDFs inline. Open the guideline in a new tab.

This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.

3 Views
0 Likes
0 Shares
0 Comments

StayCurrentMD

View profile →

Clinical Guideline

Osteosarcoma and Malignant Fibrous Histiocytoma of Bone PDQ®

Topic overview

NCI's evidence-based clinical reference for healthcare professionals treating osteosarcoma and malignant fibrous histiocytoma of bone. Covers diagnostic approaches, staging systems, treatment protocols including surgery and chemotherapy, and prognostic factors for these primary bone malignancies.

Key Takeaways

  • Osteosarcoma and malignant fibrous histiocytoma (MFH) are primary bone malignancies requiring multimodal treatment approaches.
  • PDQ® provides evidence-based, peer-reviewed treatment guidelines for health professionals managing these rare bone tumors.
  • Treatment typically involves surgical resection combined with chemotherapy to improve survival outcomes.
  • Early diagnosis and referral to specialized oncology centers improves prognosis for patients with bone sarcomas.

Keywords

Osteosarcoma Malignant Fibrous Histiocytoma Bone Tumors Pediatric Oncology Orthopedic Oncology Sarcoma Treatment Bone Cancer

Hashtags

#Osteosarcoma #BoneCancer #PediatricOncology #SarcomaTreatment

Full guideline text

Full text not available for this guideline
How to cite: GlobalCastMD. Osteosarcoma and Malignant Fibrous Histiocytoma of Bone PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2367

Comments

Loading comments...